Article abstract The MIDAS Questionnaire was developed to assess headache-related
disability with the aim of improving migraine care. Headache sufferers answer five questions, …

Objective: Zolmitriptan oral tablet is highly effective and well tolerated in the acute treatment
of migraine with and without aura in adults. A nasal spray formulation has now been …

Migraine is a remarkably disabling condition, although unpredictable and heterogeneous in
frequency, duration and severity. It can be difficult to manage in primary care, where it is …

Background Headache is the neurological symptom most frequently presented to GPs and
referred to neurologists, but little is known about how referred patients differ from patients …

Objectives.—This study investigated the disability of females who have migraine and other
headache attacks occurring during and outside the menstrual period. Methods.—One …

Objective.—This study analyzed the profile of patients who attended a specialist UK headache
clinic over a 3‐year period. Methods.—An audit was conducted of the clinical records of …

This paper aims to estimate the service and social costs of headache presenting in primary
care and to identify predictors of headache costs. Patients were recruited from GP practices …

The objective was to evaluate the efficacy and tolerability of oral sumatriptan (100 mg) in
patients who self–reported with menstrually related migraine. A prospective, multicentre, …

Part 1 of this international study was a randomised, double-blind, placebo-controlled study
of 2.5 mg and 5 mg zolmitriptan (Zomig®) in the treatment of persistent migraine headache, …

Medication overuse headache (MOH) is a common medical condition that is associated with
considerable long-term morbidity and disability. Patients experiencing MOH have primary …